登录 注册 会员服务 联系我们

Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09)

  • Published:2020-09-28 Issue:12 Volume:99 Page:2831-2836
  • ISSN:0939-5555
  • Container-title:Annals of Hematology
  • language:en
  • Short-container-title:Ann Hematol

Author:

Kang Sora,Cho Hyungwoo,Sohn Byeong Seok,Oh Sung Yong,Lee Won-Sik,Lee Sang Min,Yang Deok-Hwan,Huh Jooryung,Yoon Dok Hyun,Suh Cheolwon

Funder

Asan Institute for Life Sciences, Asan Medical Center

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Reference25 articles.

1. Pfreundschuh M, Kuhnt E, Trümper L, Österborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani P-L, Shpilberg O, Kvaloy S, Brown PN, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N, Group ftMIT (2011) CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 12(11):1013–1022. https://doi.org/10.1016/s1470-2045(11)70235-2

2. Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, Gressin R, Cornillon J, Banos A, Du KL, Benchalal M, Moles M-P, Gouill SL, Fleury J, Godmer P, Maisonneuve H, Deconinck E, Houot R, Laribi K, Marolleau JP, Tournilhac O, Branger B, Devillers A, Vuillez JP, Fest T, Colombat P, Costes V, Szablewski V, Béné MC, Delwail V (2018) R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma. Blood 131(2):174–181. https://doi.org/10.1182/blood-2017-07-793984

3. Persky DO, Unger JM, Spier CM, Stea B, LeBlanc M, McCarty MJ, Rimsza LM, Fisher RI, Miller TP (2008) Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group Study 0014. J Clin Oncol 26(14):2258–2263. https://doi.org/10.1200/jco.2007.13.6929

4. Sehn LH (2012) Chemotherapy alone for localized diffuse large B-cell lymphoma. Cancer J 18(5):421–426. https://doi.org/10.1097/ppo.0b013e31826c5907

5. Sehn LH, Savage KJ, Hoskins P, Klasa R, Shenkier T, Voss N, Wilson D, Connors JM (2007) Limited-stage diffuse large B-cell lymphoma (DLBCL) patients with a negative pet scan following three cycles of R-CHOP can be effectively treated with abbreviated chemoimmunotherapy alone. Blood 110(11):787–787. https://doi.org/10.1182/blood.v110.11.787.787

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3